RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VELICKI L
Collezione AOU Città della Salute di Torino

Items : 5

Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry. in American journal of cardiovascular drugs : drugs, devices, and other interventions / Am J Cardiovasc Drugs. 2023 Jan;23(1):77-87. doi: 10.1007/s40256-022-00554-5. Epub 2022 Oct 31.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

De Ferrari GM; Dominguez-Rodriguez A; Conrotto F; D'Ascenzo F; Kawashiri MA; Nie SP; Kawaji T; Quadri G; Huczek Z; Paz RC; Juanatey JRG; Nuñez-Gil I; Song X; Cerrato E; Rognoni A; Correia L; Xanthopoulou I; Velicki L; Wilton SB; Henriques JPS; Templin C; Iannaccone M; Liebetrau C; Manzano-Fernández S; Kinnaird T; Ariza-Solé A; Abu-Assi E; Wa?ha W; Raposeiras-Roubin S; et alii...

Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial. in Circulation / Circulation. 2022 Mar;145(9):648-658. doi: 10.1161/CIRCULATIONAHA.121.057639. Epub 2021 Nov 13.

2022
AOU Città della Salute di Torino

Nikolic SD; Van Camp G; Wojakowski W; Salizzoni S; Velicki L; Pavlovic N; Gasparovic H; Glaveckaite S; Kotrc M; Kockova R; Deja MA; Penicka M; Doros G; Putnik S; Banovic M; Iung B; Bartunek J;

Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries. in Cardiovascular drugs and therapy / Cardiovasc Drugs Ther. 2021 Dec;35(6):1171-1182. doi: 10.1007/s10557-021-07213-y. Epub 2021 Jul 5.

2021
ASL Vercelli
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cerrato E; D'Ascenzo F; Varbella F; Montagna L; De Ferrari GM; Luciano A; Dominguez-Rodriguez A; Destefanis P; Kawashiri MA; Morbiducci U; Nie SP; Huczek Z; Gonzàlez Juanatey JR; Kawaji T; Alexopoulos D; Song X; Durante A; Fujii T; Rognoni A; Ugo F; Nunez-Gil I; Correia L; Templin C; Wilton SB; Velicki L; Spirito A; Henriques JPS; Boccuzzi G; Liebetrau C; et alii...

P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects. in European heart journal. Cardiovascular pharmacotherapy / Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):31-42. doi: 10.1093/ehjcvp/pvz048.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

López-Cuenca A; Dominguez-Rodriguez A; Montefusco A; Conrotto F; Morbiducci U; Gallo D; Kawashiri MA; Muñoz Pousa I; Nie SP; Cespón Fernández M; González Juanatey JR; Huczek Z; Cobas Paz R; Caneiro Queija B; Alexopoulos D; Quadri G; Garay A; Blanco PF; Kawaji T; Varbella F; Magnani G; Gili S; Song X; Durante A; Fujii T; Taha S; Montabone A; Iannaccone M; Nuñez-Gil I; et alii...

Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor. in International journal of cardiology / Int J Cardiol. 2020 Feb 15;301:200-206. doi: 10.1016/j.ijcard.2019.11.132. Epub 2019 Nov 22.

2020
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Valgimigli M; Assi EA; Pozzi R; Iñiguez-Romo A; Dominguez-Rodriguez A; Lopez-Cuenca Á; Cequier A; Alexopoulos D; Gallo D; Morbiducci U; Paz RC; Fernández MC; Pousa IM; Queija BC; Srdanovic I; Quadri G; Garay A; Blanco PF; Giustetto C; Grosso A; Magnani G; Autelli M; Gili S; Durante A; Taha S; Rossini R; Montabone A; Bernardi A; Boccuzzi G; et alii...